Mining of publicly available Cancer Genome Atlas (TCGA) expression data identified CHKA amplification and/or mRNA upregulation in 11% of breast, 5–10% of lung, 8% of ovarian, 7% of colorectal and 5% of prostate cancers. Here, CHKA is linked to prostate carcinoma.